Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥12.4bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥22.5bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥11.4bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥1.6bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥1.9bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥1.7bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥3.5bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.9bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥1.7bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥2.1bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥1.1bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.2bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥1.5bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥34.9bnat 2025-09-30Cons.Assets
Total assets¥35.4bnat 2025-03-31Cons.Assets
Total assets¥32.6bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥10.2bnat 2025-09-30Cons.Liabilities
Total liabilities¥9.8bnat 2025-03-31Cons.Liabilities
Net assets / equity¥24.7bnat 2025-09-30Cons.Net assets
Net assets / equity¥25.5bnat 2025-03-31Cons.Net assets
Net assets / equity¥24.4bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥13.7bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥15.4bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥13.7bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥15.4bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥15.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥1.4bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.7bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥998m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥1.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.9bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥553m2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥703m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥145.462025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥292.412024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥170.42024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio66.4%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio67.8%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Medical Relatedreportable segmentrevenue2025-04-01 → 2025-09-30¥1.5bn
Medical Relatedreportable segmentrevenue external2025-04-01 → 2025-09-30¥1.5bn
Medical Relatedreportable segmentsegment profit2025-04-01 → 2025-09-30¥108m
Water Health Carereportable segmentrevenue2025-04-01 → 2025-09-30¥10.9bn
Water Health Carereportable segmentrevenue external2025-04-01 → 2025-09-30¥10.9bn
Water Health Carereportable segmentsegment profit2025-04-01 → 2025-09-30¥1.5bn
—segment totalrevenue2025-04-01 → 2025-09-30¥12.4bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥12.4bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥1.6bn
Medical Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥1.4bn
Medical Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.4bn
Medical Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
Water Health Carereportable segmentrevenue2024-04-01 → 2024-09-30¥9.9bn
Water Health Carereportable segmentrevenue external2024-04-01 → 2024-09-30¥9.9bn
Water Health Carereportable segmentsegment profit2024-04-01 → 2024-09-30¥1.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥11.4bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥11.4bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥1.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 518
ItemContextValueUnit
Valuation difference on available for sale securities net of tax ociPrior1InterimDuration-101544000JPY
Valuation difference on available for sale securities net of tax ociInterimDuration4153000JPY
Foreign currency translation adjustment net of tax ociPrior1InterimDuration118870000JPY
Foreign currency translation adjustment net of tax ociInterimDuration-143421000JPY
Remeasurements of defined benefit plans net of tax ociPrior1InterimDuration1117000JPY
Remeasurements of defined benefit plans net of tax ociInterimDuration-7164000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1InterimDuration1009000JPY
Share of other comprehensive income of associates accounted for using equity method ociInterimDuration466000JPY
Other comprehensive incomePrior1InterimDuration19452000JPY
Other comprehensive incomeInterimDuration-145966000JPY
Comprehensive incomePrior1InterimDuration1470630000JPY
Comprehensive incomeInterimDuration1016361000JPY
Comprehensive income attributable to owners of the parentPrior1InterimDuration1310834000JPY
Comprehensive income attributable to owners of the parentInterimDuration1022223000JPY
Comprehensive income attributable to non controlling interestsPrior1InterimDuration159796000JPY
Comprehensive income attributable to non controlling interestsInterimDuration-5861000JPY
Income before income taxesPrior1InterimDuration2099176000JPY
Income before income taxesInterimDuration1675039000JPY
Depreciation and amortization ope cfPrior1InterimDuration224828000JPY
Depreciation and amortization ope cfInterimDuration231190000JPY
Amortization of goodwill ope cfPrior1InterimDuration18559000JPY
Amortization of goodwill ope cfInterimDuration18559000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1InterimDuration723000JPY
Increase decrease in allowance for doubtful accounts ope cfInterimDuration-140000JPY
Increase decrease in provision for bonuses ope cfPrior1InterimDuration12017000JPY
Increase decrease in provision for bonuses ope cfInterimDuration-314000JPY
Increase decrease in provision for share based payments ope cfPrior1InterimDuration44744000JPY
Increase decrease in provision for share based payments ope cfInterimDuration46690000JPY
Increase decrease in net defined benefit liability ope cfPrior1InterimDuration11765000JPY
Increase decrease in net defined benefit liability ope cfInterimDuration11451000JPY
Increase decrease in provision for directors retirement benefits ope cfPrior1InterimDuration-30141000JPY
Increase decrease in provision for directors retirement benefits ope cfInterimDuration19714000JPY
Interest and dividends income ope cfPrior1InterimDuration-25932000JPY
Interest and dividends income ope cfInterimDuration-51770000JPY
Interest expenses ope cfPrior1InterimDuration787000JPY
Interest expenses ope cfInterimDuration2660000JPY
Equity in earnings losses of affiliates ope cfPrior1InterimDuration-12303000JPY
Equity in earnings losses of affiliates ope cfInterimDuration-8925000JPY
Loss gain on sales of investment securities ope cfPrior1InterimDuration-149274000JPY
Loss gain on sales of investment securities ope cfInterimDuration-JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1InterimDuration-484728000JPY
Decrease increase in notes and accounts receivable trade ope cfInterimDuration-663208000JPY
Decrease increase in inventories ope cfPrior1InterimDuration-12704000JPY
Decrease increase in inventories ope cfInterimDuration117814000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1InterimDuration17404000JPY
Increase decrease in notes and accounts payable trade ope cfInterimDuration69912000JPY
Increase decrease in advances received ope cfPrior1InterimDuration193691000JPY
Increase decrease in advances received ope cfInterimDuration221046000JPY
Increase decrease in accrued consumption taxes ope cfPrior1InterimDuration-74023000JPY
Increase decrease in accrued consumption taxes ope cfInterimDuration38426000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass